Hetero Targets 1.5 Million Semaglutide Pens, Eyes 75+ Markets Written By sheeba farhat16 April 2026 8:30 PM ISTHyderabad: Hetero Labs, one of India's largest privately held drugmakers, aims to sell 1.5 ​million pens of generic weight-loss and diabetes drugs in...
Hetero, Gedeon Richter Join Hands for Commercialisation of Semaglutide Injection Written By Susmita Roy10 April 2026 6:45 PM ISTNew Delhi: Gedeon Richter and Hetero Labs today announce the signing of a global collaboration agreement for the joint development, registration, and...
State Drug Alert: 141 Medicine Samples Including Mankind's Telmisartan Fail CDSCO Quality Tests in November Written By Susmita Roy23 Dec 2025 10:13 PM ISTNew Delhi: Reflecting continuing concerns over medicine quality in India's pharmaceutical supply chain, the Central Drugs Standard Control...
CDSCO Panel Rejects Hetero Lab's Plea for Lenacapavir Approval Without Local Trials Written By Parthika Patel9 Dec 2025 3:12 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has declined the proposal submitted by...
Cipla, Hetero win bid to supply widely prescribed diabetes drug in China Written By Ruchika Sharma12 Nov 2025 2:27 PM ISTBeijing: In a major breakthrough for India's pharmaceutical industry, several Indian drugmakers operating in China have made some headway into...
CDSCO Flags 112 Drug Batches Including Telmisartan, Pantoprazole, Cefixime, Glimepiride as Not of Standard Quality Written By Susmita Roy25 Oct 2025 1:53 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has identified 112 batches of medicines and medical products as "Not of Standard...
USFDA Raises Compliance Concerns at Hetero Labs' Nakkapalli Facility Written By Parthika Patel12 Oct 2025 11:15 AM ISTNakkapalli: Drug maker Hetero Labs has received a Form 483 issued by the United States Food and Drug Administration (USFDA) after six major compliance...
Game-Changer for HIV: Dr Reddy's, Hetero to Sell Generic Lenacapavir at Rs 3,547 a Year Farhat Nasim25 Sept 2025 3:51 PM ISTBengaluru: Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and highly...
Hetero Labs' Acarbose-Sitagliptin-Metformin FDC Rejected by CDSCO Panel Over GI Risk Written By Dr. Divya Colin30 Jun 2025 5:45 PM ISTNew Delhi: In a setback to Hetero Labs Limited, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation...
Hetero Labs gets CDSCO Panel nod to study Tegoprazan tablet 50 mg Written By Dr. Divya Colin13 May 2025 5:45 PM ISTNew Delhi: Responding to the proposal presented by Hetero Labs, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Hetero Labs Gets CDSCO Panel Nod To study Semaglutide Injection for Type 2 Diabetes Mellitus Written By Dr. Divya Colin10 March 2025 6:00 PM ISTNew Delhi: Hetero Labs has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Hetero Labs Gets CDSCO Panel Nod To Study Antipsychotic Drug Brexpiprazole Tablets Written By Dr. Divya Colin21 Feb 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to Hetero...
